PubMed HealthSearch

PubMed · 1841811

[Structural changes in valve prostheses].

Abstract

All available prostheses, either mechanical or biological, may undergo structural alterations which are cause of reoperation or death. Some of these complications are common to all valves, whereas some are specific for certain models. Modern mechanical prostheses usually are resistant to structural deterioration, but still thrombogenic thus requiring long-term anticoagulation therapy to avoid thrombotic and thromboembolic episodes, which implies the risk of anticoagulation related hemorrhages. Bioprostheses, on the other hand, present a lower thrombogenicity, however they undergo by definition structural degeneration, especially dystrophic calcification, which is usually cause of reoperation within 8-10 years from implantation. Other prosthetic complications, such as infective endocarditis and fibrous tissue overgrowth, are common to both types of prostheses.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Minarini, A F Maizza, G Thiene. 1991. [Structural changes in valve prostheses].. https://pubmed.ncbi.nlm.nih.gov/1841811/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients.

To assess the results and incremental risk factors affecting outcome after multiple-valve operation in the early blood cardioplegia era of cardiac surgery, follow-up data (mean +/- SD 3.1 +/- 2 years) were obtained on 97% of 513 patients (mean age +/- SD 58.8 +/- 10.5 years) who underwent a multiple-valve procedure between June 1976 and August 1985. Preoperatively 41% of patients were in New York Heart Association functional class III and 54% in class IV. Three groups accounted for 98.6% of the patients: 57.7% had an aortic and mitral valve procedure, 29% had a mitral and tricuspid valve procedure and 11.9% had a triple-valve procedure. The overall hospital mortality rate was 12.5% and overall 5-year survival rate was 67.1%. Hazard function analysis for all deaths revealed systolic pulmonary artery pressure (p less than 0.0001), age (p = 0.005), triple valve procedure (p less than 0.005), concomitant coronary bypass operation (p less than 0.005) and prior cardiac surgery (p less than 0.002) as the significant incremental risk factors predicting decreased survival in the early hazard phase; diabetes (p less than 0.005) predicted decreased survival in the late hazard phase. Postoperatively the condition of 80% of the patients improved to functional class I or II; only 0.6% remained in functional class IV. The 5-year rate of freedom from late combined valve-related morbidity was 81.7% and that of freedom from late combined valve-related morbidity and mortality was 71.7%. These results demonstrate excellent clinical improvement and late survival after multiple valve operation in patients with advanced valvular heart disease, justifying aggressive surgical therapy in these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Bioprosthesis